Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 198 Records) |
| Query Trace: Cancer genomics[original query] |
|---|
| African-specific molecular taxonomy of prostate cancer. Nature 2022 8 609 (7927): 552-559. Jaratlerdsiri Weerachai, Jiang Jue, Gong Tingting, Patrick Sean M, Willet Cali, Chew Tracy, Lyons Ruth J, Haynes Anne-Maree, Pasqualim Gabriela, Louw Melanie, Kench James G, Campbell Raymond, Horvath Lisa G, Chan Eva K F, Wedge David C, Sadsad Rosemarie, Brum Ilma Simoni, Mutambirwa Shingai B A, Stricker Phillip D, Bornman M S Riana, Hayes Vanessa |
| Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas. Cancer genomics & proteomics 0 19 (5): 556-569. Karihtala Peeter, Porvari Katja, Kilpivaara Ou |
| Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer. Experimental and therapeutic medicine 2022 8 24 (3): 542. Jie Xiaoxiang, Du Ming, Zhang Meng, Jin Xiayu, Cai Qingqing, Xu Congjian, Zhang Xiaoy |
| Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis. Clinical genitourinary cancer 2022 Jun . Rizzo Alessandro, Mollica Veronica, Santoni Matteo, Massari Frances |
| Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer. Cancer genomics & proteomics 0 19 (4): 464-476. Stella Stefania, Vitale Silvia Rita, Massimino Michele, Motta Gianmarco, Longhitano Claudio, Lanzafame Katia, Martorana Federica, Fazzari Carmine, Vecchio Giada Maria, Tirrò Elena, Inzerilli Nicola, Carciotto Rosaria, Manzella Livia, Caruso Michele, Vigneri Pao |
| The Contribution of PDCD6 Polymorphisms to Oral Cancer Risk. Cancer genomics & proteomics 0 19 (4): 456-463. Shih Liang-Chun, He Jie-Long, Chang Wen-Shin, Hsu Che-Lun, Hsia Te-Chun, Wang Yun-Chi, Yang Jia-Sing, Mong Mei-Chin, Tsai Chia-Wen, Bau DA-Ti |
| Characterizing the mutational landscape of MM and its precursor MGUS. American journal of cancer research 2022 12 (4): 1919-1933. Farswan Akanksha, Gupta Anubha, Jena Lingaraja, Ruhela Vivek, Kaur Gurvinder, Gupta Ri |
| Colorectal Cancer Genomics by Genetic Ancestry. Cancer discovery 2022 05 12 (5): 1187-1188. Eng Cathy, Holowatyj Andreana |
| Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer. Cancer causes & control : CCC 2022 4 33 (6): 831-841. Hercules Shawn M, Liu Xiyu, Bassey-Archibong Blessing B I, Skeete Desiree H A, Smith Connell Suzanne, Daramola Adetola, Banjo Adekunbiola A, Ebughe Godwin, Agan Thomas, Ekanem Ima-Obong, Udosen Joe, Obiorah Christopher, Ojule Aaron C, Misauno Michael A, Dauda Ayuba M, Egbujo Ejike C, Hercules Jevon C, Ansari Amna, Brain Ian, MacColl Christine, Xu Yili, Jin Yuxin, Chang Sharon, Carpten John D, Bédard André, Pond Greg R, Blenman Kim R M, Manojlovic Zarko, Daniel Juliet |
| Role of Genetic Variations in CDK2, CCNE1 and p27 in Prostate Cancer. Cancer genomics & proteomics 2022 4 19 (3): 362-371. Híveš Márk, Jure?eková Jana, Kliment Ján, Grendár Marián, Kaplán Peter, Dušenka Róbert, Evin Daniel, Vil?ková Marta, Hole?ková Klaudia Híveš, Sivo?ová Monika Kme?o |
| PTPN14 Mutations and Cervical Cancer. Cancer diagnosis & prognosis 2022 4 1 (4): 275-277. Lehrer Steven, Rheinstein Peter |
| Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma. Discover. Oncology 2022 11 13 (1): 131. Kong Fanhua, Wang Kunpeng, Wang Liez |
| A novel signature based on pyroptosis-related genes for predicting prognosis and treatment response in prostate cancer patients. Frontiers in genetics 2022 11 13 1006151. Xiao Xi, Li Jianpeng, Wan Shun, Wu Mingzhe, Li Zonglin, Tian Junqiang, Mi J |
| Mesonephric-like Carcinosarcoma of the Uterine Corpus: Clinicopathological, Molecular and Prognostic Characteristics in Comparison With Uterine Mesonephric-like Adenocarcinoma and Conventional Endometrial Carcinosarcoma. Cancer genomics & proteomics 2022 10 19 (6): 747-760. Park Sujin, Park Eunhyang, Kim Hyun-S |
| Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung. Frontiers in oncology 2022 12 945843. Wang Hongbiao, Liu Jun, Zhu Sujuan, Miao Kun, Li Zhifeng, Qi Xiaofang, Huang Lujia, Guo Lijie, Wang Yan, Cai Yuyin, Lin Yingche |
| Large-scale phenogenomic analysis of human cancers uncovers frequent alterations affecting SMC5/6 complex components in breast cancer. NAR cancer 2023 9 5 (3): zcad047. Shamayita Roy, Arvin Zaker, Arvind Mer, Damien D'Amou |
| Genomic characterization of thymic epithelial tumors in a real-world dataset. ESMO open 2023 9 8 (5): 101627. K Kurokawa, T Shukuya, R A Greenstein, B G Kaplan, H Wakelee, J S Ross, K Miura, K Furuta, S Kato, J Suh, S Sivakumar, E S Sokol, D P Carbone, K Takahas |
| Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients. Genome medicine 2023 9 15 (1): 65. Mohammed Al-Jumaan, Hoyin Chu, Abdullah Alsulaiman, Sabrina Y Camp, Seunghun Han, Riaz Gillani, Yousef Al Marzooq, Fatmah Almulhim, Chittibabu Vatte, Areej Al Nemer, Afnan Almuhanna, Eliezer M Van Allen, Amein Al-Ali, Saud H AlDubay |
| CYBA as a Potential Biomarker for Renal Cell Carcinoma: Evidence from an Integrated Genetic Analysis. Cancer genomics & proteomics 2023 8 20 (5): 469-475. Chi-Fen Chang, Shu-Pin Huang, Yu-Mei Hsueh, Pei-Ling Chen, Cheng-Hsueh Lee, Jiun-Hung Geng, Chao-Yuan Huang, Bo-Ying B |
| Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer. Cancer genomics & proteomics 2023 8 20 (5): 417-432. Yaroslav Ilnytskyy, Lars Petersen, John B McIntyre, Mie Konno, Adrijana D'Silva, Michelle Dean, Anifat Elegbede, Andrey Golubov, Olga Kovalchuk, Igor Kovalchuk, Gwyn Be |
| Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing. Cancer genomics & proteomics 2023 8 20 (5): 448-455. Konstantinos Agiannitopoulos, Georgia Pepe, Georgios N Tsaousis, Kevisa Potska, Dimitra Bouzarelou, Anastasia Katseli, Christina Ntogka, Angeliki Meintani, Nikolaos Tsoulos, Stylianos Giassas, Vassileios Venizelos, Christos Markopoulos, Rodoniki Iosifidou, Sofia Karageorgopoulou, Christos Christodoulou, Ioannis Natsiopoulos, Konstantinos Papazisis, Maria Vasilaki-Antonatou, Eleftherios Kabletsas, Amanta Psyrri, Dimitrios Ziogas, Efthalia Lalla, Anna Koumarianou, Kornilia Anastasakou, Christos Papadimitriou, Vahit Ozmen, Sualp Tansan, Kerim Kaban, Tahsin Ozatli, Dan Tudor Eniu, Angelica Chiorean, Alexandru Blidaru, Marrit Rinsma, Eirini Papadopoulou, George Nasioul |
| Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma. Cancer genomics & proteomics 2023 7 20 (4): 404-411. Vlastimil Kulda, Jiri Polivka, Martin Svaton, Tomas Vanecek, Marcela Buresova, Katerina Houfkova, Mahyar Sharif Bagheri, Tereza Knizkova, Bohuslava Vankova, Jindra Windrichova, Petr Macan, Vaclav Babuska, Martin Pes |
| High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology. Cancer treatment and research communications 2023 7 36 100746. Ioannis A Voutsadak |
| CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database. Japanese journal of clinical oncology 2023 6 . Kenya Kobayashi, Yuki Saito, Hidenori Kage, Osamu Fukuoka, Koji Yamamura, Toshiyuki Mukai, Katsutoshi Oda, Tatsuya Yamaso |
| Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes. European urology 2023 5 . Louise C Pyle, Jung Kim, Jonathan Bradfield, Scott M Damrauer, Kurt D'Andrea, Lawrence H Einhorn, Rama Godse, Hakon Hakonarson, Peter A Kanetsky, Rachel L Kember, Linda A Jacobs, Kara N Maxwell, Daniel J Rader, David J Vaughn, Benita Weathers, Bradley Wubbenhorst, Regeneron Genetics Center Research Team, Cancer Genomics Research Laboratory, Mark H Greene, Katherine L Nathanson, Douglas R Stewa |
| Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes? Abdominal radiology (New York) 2023 3 . Liu Xiaoyang, Guo Yang, Zhao Lei, Misdraji Joseph, Kapur Tina, Abrams Thomas A, Shyn Paul |
| Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer. Journal of racial and ethnic health disparities 2023 2 . Lee Kristi Y, Beatson Erica L, Steinberg Seth M, Chau Cindy H, Price Douglas K, Figg William |
| Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival. Cancer genomics & proteomics 2023 10 20 (6): 626-636. Hyunwoo Yoo, Hyun-Soo K |
| Oncogenic context shapes the fitness landscape of tumor suppression. Nature communications 2023 10 14 (1): 6422. Lily M Blair, Joseph M Juan, Lafia Sebastian, Vy B Tran, Wensheng Nie, Gregory D Wall, Mehmet Gerceker, Ian K Lai, Edwin A Apilado, Gabriel Grenot, David Amar, Giorgia Foggetti, Mariana Do Carmo, Zeynep Ugur, Debbie Deng, Alex Chenchik, Maria Paz Zafra, Lukas E Dow, Katerina Politi, Jonathan J MacQuitty, Dmitri A Petrov, Monte M Winslow, Michael J Rosen, Ian P Winte |
| Analysis of eEF1A2 gene expression and copy number in cervical carcinoma. Medicine 2023 1 102 (2): e32559. Zheng Weinan, Jin Fuyuan, Wang Fang, Wang Luyue, Fu Shaowei, Pan Zemin, Long Haich |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: